UroGen Pharma
Price & Volume
Stats
See more52W Range | $3.42-$30 |
Market Cap | $1.2B |
Shares Short | 8M |
Financials
See moreRevenue (12 Mos) | $96.5M |
Revenue Growth (YoY) | 9% |
Gross Profit (12 Mos) | $84.8M |
Diluted EPS | -$3.47 |
News
See moreYahoo Finance • 3 days ago
UroGen Pharma to Present at the Piper Sandler 37th Annual Healthcare Conference
Yahoo Finance • 21 days ago
UroGen outlines $1B ZUSDURI peak revenue ambition as adoption set to accelerate with permanent J-code in 2026
Yahoo Finance • 22 days ago
UroGen Reports 77.8% Three-Month Complete Response Rate from Phase 3 UTOPIA Trial of UGN-103 and Receives FDA Agreement on NDA Submission Strategy in Recurrent LG-IR-NMIBC Based on UTOPIA Trial
Yahoo Finance • 29 days ago
UroGen Pharma to Report Third Quarter 2025 Financial Results on Thursday, November 6th, 2025
About
CEO | Ms. Elizabeth A. Barrett |
Address | 400 Alexander Park Drive, Princeton, NJ, United States, 08540 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 287 |
